Physical & Occupational Therapy for Parkinson Disease: The Science and Practice of LSVT BIG™

You are invited to attend a two-hour interactive symposium on movement disorders and physical and occupational treatment for people with Parkinson disease (PD).

This symposium is FREE so it is a wonderful opportunity for people with PD, family members and friends, and other healthcare professionals who want to learn more about movement and PD to attend.

The symposium will include a 1-hour lecture presented by world experts in physical/occupational therapy for people with Parkinson Disease. This lecture will be followed by an interactive session where participants with PD are invited to interact with physical or occupational therapists practicing Parkinson-specific movement exercises (LSVT BIG). Please wear comfortable clothing to the event.

Where:

Crowne Plaza St. Louis-Clayton
Grand Ballroom
7750 Carondelet Avenue
St. Louis (Clayton), MO 63105

Click Here For Directions

When:

Sunday, September 30, 2012
12:30 – 1:30 p.m. Lecture (details below) and refreshments
1:30-2:30 p.m. Interactive demonstration with LSVT BIG

RSVP:

Please RSVP to LSVT Global at:
Toll Free: 1-888-438-5788 Direct: 1-520-867-8838 Fax: 1-520-867-8839
Email: info@LSVTGlobal.com

Lecture Summary

The LSVT (Lee Silverman Voice Treatment) Programs for individuals with PD have been developed and researched over the past 20 years beginning with a focus on the speech motor system (LSVT LOUD™) and more recently have been extended to address limb motor systems (LSVT BIG). This presentation will: 1) briefly explain recent advances in neuroscience that have had a positive impact on the field of rehabilitation for individuals with PD, 2) discuss the development and data on an efficacious speech treatment LSVT LOUD, 3) describe development and key aspects of limb motor treatment LSVT BIG, 4) briefly describe the LSVT HYBRID™ approach (simultaneous delivery of BIG and LOUD), and 5) highlight future directions for innovative technology to enhance accessibility of treatment for all individuals with PD who can benefit.

This research was funded, in part, by the National Institutes of Health and Michael J Fox Foundation.

Webcasts:

July 2012 Webcasts

Comments are closed.